Single-dose psilocybin treatment for major depressive disorder: A randomized clinical trial
CL Raison, G Sanacora, J Woolley, K Heinzerling… - Jama, 2023 - jamanetwork.com
… treatments for major depressive disorder (MDD) 1 -5 and in part by recent studies suggesting
that psilocybin engenders a rapid … lost to follow-up; 3 participants in the psilocybin group …
that psilocybin engenders a rapid … lost to follow-up; 3 participants in the psilocybin group …
Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up
… outcome measure (Quick Inventory of Depressive Symptoms). … depression severity scores
favored the high-dose psilocybin … Although psilocybin treatment of MDD appears promising, …
favored the high-dose psilocybin … Although psilocybin treatment of MDD appears promising, …
The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis
… anxiety and depression in samples with elevated symptoms. … pre-follow-up effects on anxiety
and depression were large (… Rapid and sustained symptom reduction following psilocybin …
and depression were large (… Rapid and sustained symptom reduction following psilocybin …
Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial
… with major depressive disorder and treatment-resistant depression (… model of depression,
ketanserin followed by psilocybin had … ’s antidepressant effects may be mediated through rapid …
ketanserin followed by psilocybin had … ’s antidepressant effects may be mediated through rapid …
[HTML][HTML] Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
R von Rotz, EM Schindowski, J Jungwirth… - …, 2023 - thelancet.com
… 25 mg, 7 days apart) together with psychological support resulted in rapid symptom
improvement in patients with treatment-resistant depression that persisted at a 6 months follow-up. …
improvement in patients with treatment-resistant depression that persisted at a 6 months follow-up. …
[HTML][HTML] Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of …
GM Goodwin, ST Aaronson, O Alvarez, M Atli… - Journal of Affective …, 2023 - Elsevier
… (the day after psilocybin administration) and … Psilocybin was also rapid-acting, with treatment
differences observed as early as Day 2 on the QIDS-SR-16 and PANAS total scores after …
differences observed as early as Day 2 on the QIDS-SR-16 and PANAS total scores after …
Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial
AK Davis, FS Barrett, DG May, MP Cosimano… - JAMA …, 2021 - jamanetwork.com
… rapid, large decrease in mean (SD) depression score among participants from baseline to day
1 after psilocybin … This substantial decrease remained through week 4 after session 2 (6.0 […
1 after psilocybin … This substantial decrease remained through week 4 after session 2 (6.0 […
… mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression
… FC after psilocybin in 19 patients with TRD who underwent two psilocybin-assisted therapy
… the criteria for severe or very severe depression (self-rated Quick-Inventory of Depressive …
… the criteria for severe or very severe depression (self-rated Quick-Inventory of Depressive …
Acute and sustained reductions in loss of meaning and suicidal ideation following psilocybin-assisted psychotherapy for psychiatric and existential distress in life …
… controlled trial in which psilocybin-assisted psychotherapy (PAP) produced rapid and … that
psilocybin treatment would be associated with significant acute and sustained reductions in SI …
psilocybin treatment would be associated with significant acute and sustained reductions in SI …
[HTML][HTML] Single-dose psilocybin for a treatment-resistant episode of major depression
GM Goodwin, ST Aaronson, O Alvarez… - … Journal of Medicine, 2022 - Mass Medical Soc
… After at least 6 hours and when the psychedelic effects of the drug had fully dissipated,
participants returned home. The trial followed participants for 12 weeks after treatment. …
participants returned home. The trial followed participants for 12 weeks after treatment. …